Background: The retinal pigment epithelium (RPE) has been implicated in the development of diabetic retinopathy and it has been suggested that insulin-like growth factors (IGF) and glucose may be among those factors which are responsible for the RPE changes in diabetics. The purpose of this study was to investigate the effect of IGF-1, IGF-2, and glucose on the migration and proliferation of bovine RPE cells in vitro. Methods: Primary cultures of bovine RPE cells were established from freshly enucleated eyes and passages 5–8 were used for these experiments. RPE cell migration was studied in confluent RPE cultures grown in multiwell plates. After inhibition of proliferation with mitomycin C (10 µg/ml) and partial denudation of the RPE in each well, the cells were incubated with IGF-1 (10 ng/ml), IGF-2 (10 ng/ml) or glucose (10 mM). Migration was measured as the number of cells that had entered the denuded area after 20 h. RPE cell proliferation was determined by [3H]-thymidine incorporation after incubation with IGF-1, IGF-2, and glucose for 24 h. Statistical analysis was performed with the paired Student’s t test. Results: Exposure of RPE cells to IGF-1, IGF-2, and glucose resulted in a significantly higher RPE cell migration as compared to the control medium (p < 0.008) with 21, 20, 17, and 9 cells/raster field, respectively. Additionally, IGF-1 (p = 0.004) and IGF-2 (p = 0.008) but not glucose caused a statistically significant stimulation of DNA synthesis with 761, 747, and 593 ccpm, respectively, as compared to the negative control (352 ccpm). Conclusion: This study indicates that IGF-1 and IGF-2 influence RPE cell migration and proliferation. This is further evidence that these factors are among those which have to be kept in mind when trying to modulate the development of diabetic eye diseases.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.